The Trump administration allocated $500 million to a universal vaccine initiative, a significant sum amidst budget cuts affecting other health research.
This investment contrasts with the administration's focus on next-generation Covid-19 vaccines.
The project is spearheaded by two scientists recently appointed to high-ranking positions at the National Institutes of Health (NIH).
This funding decision raises questions about priorities in healthcare investment given the simultaneous budget reductions and grant terminations within health agencies.
Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Skip the extension — just come straight here.
We’ve built a fast, permanent tool you can bookmark and use anytime.
Go To Paywall Unblock Tool